Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 7β HSDH Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107099516B reveals a stable 7β-hydroxysteroid dehydrogenase mutant enabling high-concentration ursodeoxycholic acid synthesis with superior thermal stability and simplified downstream processing.
Patent CN108546691B discloses a novel 7β-HSDH mutant utilizing cheap NADH for ursodeoxycholic acid production, offering significant cost reduction and scalable biocatalysis solutions.